American Society of Clinical Oncology (ASCO)
MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MH WELLNESS FAIR 2025, CHAMPIONING HEALTHY YOUTHS
KUALA LUMPUR, Malaysia, Aug. 23, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC) today launches the first edition of its MH Wellness Fair 2025 series, themed "Young & Healthy Champions", in conjunction with the United Nations' International Youth Day that is celebrated every 12...
MTE Hanoi 2025: Unlocking Opportunities in Vietnam's Hospitality & Real Estate
October 1, 2025 | Ascott Tay Ho Hanoi HO CHI MINH CITY, Vietnam, Aug. 20, 2025 /PRNewswire/ -- Vietnam's hospitality and real estate sectors continue to advance, showing clear signs of strong recovery, with extensive pipelines ready for launch.Hanoi is emerging as a key hub for branded residence...
Announcing HorecFex Vietnam 2025: The Convergence of Leading Solutions, Technologies and Trends in the HORECA Industry
DA NANG, Vietnam, Aug. 15, 2025 /PRNewswire/ -- HorecFex Vietnam, in collaboration with the Vietnam Hotel Association and the Ariyana International Convention Centre, officially announces the HorecFex 2025 event – the Exhibition and Forum for Innovation and Technology in the HORECA industry – to ...
Tag along with Jay at CISCE: 3, 2, 1, Go! Linking you to a better lifestyle
BEIJING, July 22, 2025 /PRNewswire/ -- This is a report from?China.org.cn:   British visitor Jay Ian Birbeck explored the healthy life section of the third China International Supply Chain Expo (CISCE), an event showcasing the full breadth of the global supply chain inBeijin...
Malaysia Airlines Takes Centre Stage as Official Airline Partner at Travel Madness Expo 2025
KUALA LUMPUR, Malaysia, July 11, 2025 /PRNewswire/ -- Malaysia Airlines is proud to announce its participation as the Official Airline Partner of the Travel Madness Expo (TME) 2025, one of the Philippines' biggest travel and trade fairs, happening from 11 July until 13 July 2025 at Hall 1-4, SMX ...
Tohoku Kizuna Festival Parade Brings Together Six Tohoku Festivals to Captivate Audience: "Tohoku Four Seasons & Tohoku Kizuna Festival" at EXPO 2025 Osaka, Kansai, Japan
SENDAI, Japan, June 26, 2025 /PRNewswire/ -- The six Tohoku prefectures, Tohoku Tourism Promotion Organization, and Tohoku Kizuna Festival Executive Committee held the "Tohoku Four Seasons & Tohoku Kizuna Festival" at 2025 Osaka, Kansai, Expo from Friday, June 13, to Sunday, June 15, 2025. The fe...
New data from DR.CI:LABO? at IMCAS Asia 2025 reinforces leadership in adjunctive clinical skincare for daily and post-IPL care for Asian skin
SINGAPORE, June 10, 2025 /PRNewswire/ -- DR.CI:LABO?, Japan's clinic-born leading derma-cosmetics brand, unveiled new findings at IMCAS Asia 2025, reaffirming its position as the go-to skincare brand for Asian skin. The data demonstrated the efficacy of VC100 Essence Lotion EX and 377VC Radian...
Highlights in Oral Presentation of Mabwell's 9MW2821 at 2025 ASCO
SHANGHAI, June 5, 2025 /PRNewswire/ --?At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held inChicago, USA, from May 30 to June 3, the results of the Phase Ib/II clinical study of 9MW2821 in combination with Toripalimab for the treatment of patients with locally advanced o...
Hengrui Pharma Showcases Global Impact at the 2025 ASCO: 72 Study Results Highlight Chinese Cancer Innovation
SHANGHAI, June 5, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting successfully concluded inChicago on June 3 (local time).?Hengrui Pharma delivered a strong international presence, featuring 15 innovative drugs and 72 research outcomes. These included 4 oral presentations, 5 rapid oral present...
Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting
SHANGHAI and CHICAGO, June 4, 2025 /PRNewswire/ -- The 2025?ASCO Annual Meeting is taking place inChicago, US, from May 30 to June 3. Duality Bio (HKEX: 9606.HK) presented the preliminary data of two clinical trials, HER3 ADC candidate DB-1310 and B7H3 ADC candidate DB-1311/BNT324, which is being...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 2, 2025 /PRNewswire/ --?Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
SAN FRANCISCO and?SUZHOU, China, June 2, 2025 /PRNewswire/ --?Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...
VINEXPO ASIA 2025 OFFERS CLARITY FOR ASEAN TRADE IN SHIFTING LANDSCAPE
SINGAPORE, June 3, 2025 /PRNewswire/ -- In a shifting global landscape, clarity matters. From 27 to 29 May, Vinexpo Asia 2025 gathered8,998 trade participants at Marina Bay Sands, reinforcing its position as both a business catalyst and a strategic forum for market orientation and collective fore...
Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU?) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
* Preliminary efficacy analysis from the?elacestrant plus everolimus and ribociclib cohorts of the ELEVATE study, along with updated safety data from additional cohorts of elacestrant plus targeted therapy combination arms, will be presented. * These data highlight elacestrant's potential ro...
Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting
CHENGDU, China, May 23, 2025 /PRNewswire/ -- The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, the "Company") will present results from six cl...
Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025
* ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy, KEYTRUDA? (pembrolizumab),?achieved an overall response rate (ORR) of 36.4% and disease control rate (DCR) of 100% in checkpoint inhibitor (CPI)-resistant melanoma patients in the ongoing STAMINA-01 t...
Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting
CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I TM), today announced that its?collaborator, Pfizer, will present an abstract detailing the first-in-human Phase 1 clinical study design of MesoC...
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting
Abstract Released for E7386, Co-Developed Through Collaborative Research Between Eisai and PRISM TOKYO, May 22, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI...
VINEXPO ACADEMY LEADS THE CONVERSATION AT VINEXPO ASIA 2025
SINGAPORE, May 21, 2025 /PRNewswire/ -- Inresponse to the rapid transformation in the global wine and spirits trade, Vinexpo Asia 2025 returns to Singapore with an expanded and strategically curated Vinexpo Academy programme. Held at Marina Bay Sands from 27–29 May, the event will feature more th...
Questex's IHIF Asia Unveils 2025 Conference Programme, Unites Hospitality Community in the Asia-Pacific Region to Connect Capital with Investment Opportunities
Registration Open for September 2025 Event HONG KONG, May 19, 2025 /PRNewswire/ -- Questex's International Hospitality Investment Forum (IHIF) Asia ?today unveils the 2025 conference programme. IHIF Asia offers an?unparalleled lineup of speakers and sessions designed t...
Week's Top Stories
Most Reposted
Hyatt Regency Kuala Lumpur At KL Midtown Debuts As The City's Ultimate Convention & Leisure Destination
[Picked up by 286 media titles]
2025-08-26 22:35
Mastercard Announces Leadership Transition in Asia Pacific
[Picked up by 277 media titles]
2025-08-26 09:26
MetaOptics Ltd Registers Offer Document on its Listing on SGX Catalist
[Picked up by 276 media titles]
2025-09-01 19:53Asia's Biggest Sustainability Expo Opens in September! Over 100 Exhibitors Join to Charge Towards Change
[Picked up by 274 media titles]
2025-08-26 09:50
Hyundai Motor Group Presents Hydrogen Vision for Energy Transition at CEM16
[Picked up by 274 media titles]
2025-08-27 09:08
